Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) CEO Jitendra Mohan sold 171,064 shares of Astera Labs stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $103.53, for a total transaction of $17,710,255.92. Following the completion of the sale, the chief executive officer now owns 628,895 shares in the company, valued at $65,109,499.35. The trade was a 21.38 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Jitendra Mohan also recently made the following trade(s):
- On Monday, November 25th, Jitendra Mohan sold 173,366 shares of Astera Labs stock. The shares were sold at an average price of $110.12, for a total value of $19,091,063.92.
- On Friday, October 11th, Jitendra Mohan sold 47,667 shares of Astera Labs stock. The shares were sold at an average price of $70.26, for a total value of $3,349,083.42.
Astera Labs Stock Down 5.6 %
Astera Labs stock opened at $99.60 on Thursday. The stock’s 50 day moving average is $73.12 and its 200-day moving average is $60.57. Astera Labs, Inc. has a 12 month low of $36.22 and a 12 month high of $113.85.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on ALAB shares. Evercore ISI dropped their price objective on Astera Labs from $98.00 to $80.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. Barclays increased their price target on shares of Astera Labs from $70.00 to $87.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Roth Mkm boosted their price objective on shares of Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Craig Hallum raised their target price on shares of Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Finally, Needham & Company LLC reissued a “buy” rating and set a $65.00 price target on shares of Astera Labs in a research report on Wednesday, October 9th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Astera Labs presently has a consensus rating of “Buy” and an average price target of $94.67.
Check Out Our Latest Report on ALAB
Institutional Trading of Astera Labs
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Avior Wealth Management LLC bought a new position in shares of Astera Labs during the third quarter worth approximately $361,000. Sei Investments Co. bought a new position in Astera Labs during the 1st quarter worth $952,000. Meeder Asset Management Inc. bought a new position in Astera Labs during the 3rd quarter worth $1,141,000. Bank of Hawaii acquired a new position in Astera Labs in the 3rd quarter valued at $1,409,000. Finally, Vanguard Group Inc. bought a new stake in shares of Astera Labs during the 1st quarter valued at $127,268,000.
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Recommended Stories
- Five stocks we like better than Astera Labs
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are Dividends? Buy the Best Dividend Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.